Stephen H. Sheldon, D.O., FAAP
Chicago, Illinois, United States
Pediatrician in Chicago, Illinois
225 E Chicago Ave, Chicago, IL 60611
About Stephen H. Sheldon, D.O., FAAP
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Stephen H. Sheldon, D.O., FAAP
During the past decade, Stephen H. Sheldon, D.O., FAAP conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
1999-07-01
2007-07-01
Completed
375
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
2005-11-01
2018-08-01
Completed
592
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
2004-09-01
2010-10-01
Completed
97
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Stephen H. Sheldon, D.O., FAAP
According to Clinical.Site data, the most researched conditions in "Stephen H. Sheldon, D.O., FAAP" are
"Narcolepsy" (2 trials) and "Sleep Apnea, Obstructive" (2 trials). Many other conditions were trialed in "Stephen H. Sheldon, D.O., FAAP" in a lesser frequency.
Clinical Trials Intervention Types at Stephen H. Sheldon, D.O., FAAP
Most popular intervention types in "Stephen H. Sheldon, D.O., FAAP" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Modafinil" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Stephen H. Sheldon, D.O., FAAP
The vast majority of trials in "Stephen H. Sheldon, D.O., FAAP" are
3 trials for "All" genders.
Clinical Trials Status at Stephen H. Sheldon, D.O., FAAP
Currently, there are NaN active trials in "Stephen H. Sheldon, D.O., FAAP".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Stephen H. Sheldon, D.O., FAAP,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stephen H. Sheldon, D.O., FAAP, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".